Clinical Immunology and Immunopathology · 1998 · 25 citations · 24 references
Life SciencesBiochemistryNutritional SciencesHuman NutritionNeurodegenerationNutritional BiochemistryAlzheimer DiseaseAmyloid FormationBioactive Food ComponentsNeurodegenerative DiseasesNeurodegenerative DisordersProtein Aggregation DisordersAmyloid A AmyloidosisAmyloid ClearanceAmyloid NucleationAmyloid SeedingAmyloid ToxicityAmyloidogenic ProteinsSerum Amyloid A Protein
The etiology and pathogenesis of amyloid A (AA) amyloidosis that may occur as an occasional complication of chronic inflammatory and infectious diseases are poorly understood. The preamyloid phase of experimentally induced AA amyloidosis can be greatly shortened in recipient animals by intravenous or intraperitoneal transfer of amyloid enhancing factor (AEF) when there is a concomitant inflammatory episode. AEF is an operational term applied to poorly characterized tissue extracts and increased AEF activity that precedes amyloid deposition. We now report that AA is rapidly formed in mice following oral administration of an AEF preparation that does not contain AA peptides. This finding indicates that a transmissible agent present in diet may be a contributory factor in amyloid fibril formation.
24
Mice devoid of PrP are resistant to scrapie
Hansruedi Büeler, Adriano Aguzzi, Andreas W. Sailer et al. · Cell · 1993 · 2.1K citations · Full text
Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent
M. E. Bruce, Robert Will, James W. Ironside et al. · Nature · 1997 · 2K citations
Scrapie prions aggregate to form amyloid-like birefringent rods
Stanley B. Prusiner, Michael P. McKinley, Karen A. Bowman et al. · Cell · 1983 · 1K citations